Deep Blue key facts
as of Oct 2026- Developer of surgical textile implants designed to reduce the occurrence and recurrence of abdominal wall defects.
- Deep Blue is valued at approximately $22.0M as of Oct 2026 (last reported valuation).
- It has raised $17.9M; the latest was Later Stage VC ($5.3M) in Sep 2025.
- Notable investors include US National Science Foundation, Band of Angels, Duke Capital Partners, SeedFolio, Triangle Angel Partners — 20 tracked in total.
- Status: Privately Held (backing).
Deep Blue's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·The complete investor list: 20 names
- ·Watch Deep Blue: the Monday email on marks, rounds and moves
Deep Blue funding rounds
No funding rounds for Deep Blue are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Deep Blue
20+Deep Blue valuation
Deep Blue's last reported valuation was $22 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
Deep Blue investors
20 investors are on record for Deep Blue, including US National Science Foundation, Band of Angels, Duke Capital Partners and SeedFolio.
About Deep Blue
Developer of surgical textile implants designed to reduce the occurrence and recurrence of abdominal wall defects. The company offers a monofilament polypropylene mesh featuring integrated extensions that distribute tension across a larger surface area while eliminating the need for traditional fixation methods, enabling surgeons and medical facilities to improve patient outcomes through increased anchoring strength and reduced tissue stress at the operative site.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2015
- Employees
- 10
- Website
- deepbluemedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.